828 WINTER STREET, WALTHAM, MA
Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates
Director Resignation and Re-Appointment - Daniel Curran, M.D.
Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
Annual Report to Security Holders
Cheryl R. Blanchard Elected as Director and Compensation Committee Chair
Financial Results, Press Release
Announces 1-for-14 Reverse Stock Split
Investor Presentation
Q2
Q1
FY 2025
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload